Development of Cross-Reactive Antibodies for the Identification and Treatment of Synthetic Cannabinoid Receptor Agonist Toxicity

Synthetic cannabinoid receptor agonists (SCRAs) are compounds that mimic the pharmacology of the psychoactive components in cannabis. These compounds are structurally diverse, inexpensive, commercially available, and difficult to identify with modern analytical methods, making them highly accessible...

Descripción completa

Detalles Bibliográficos
Autores principales: Worob, Adam, Wenthur, Cody J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415894/
https://www.ncbi.nlm.nih.gov/pubmed/36016144
http://dx.doi.org/10.3390/vaccines10081253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415894/
https://www.ncbi.nlm.nih.gov/pubmed/36016144
http://dx.doi.org/10.3390/vaccines10081253

Ejemplares similares